Why Seattle Genetics Stock Jumped 24% in September
Seattle Genetics (NASDAQ: SGEN) shareholders outpaced a declining market in September as the stock jumped 24% compared to the S&P 500's 3.9% drop, according to data provided by S&P Global Market Intelligence.
That surge added to a broader rally for the biotech company; its shares are up by more than 70% so far in 2020.
Image source: Getty Images.
Source Fool.com
